Results 241 to 250 of about 556,132 (392)

A pH‐Responsive Biomimetic Antioxidant Nanoplatform with Dual Renal Targeting for Synergistic Therapy of Acute Kidney Injury

Advanced Science, EarlyView.
A biomimetic nanoplatform (CeAst@MK) is engineered for precise therapy of acute kidney injury by integrating cerium‐based antioxidation, natural flavonoid astragalin, and macrophage membrane camouflage. Featuring kidney‐targeted and pH‐responsive release, CeAst@MK scavenges ROS, suppresses inflammation, and restores renal function via modulation of ...
Shichao Zhang, Yuhan Xie, Longchao Zhang, Yuanjiong Qi, Quan Liao, Chenglong Xu, Shushuai Yang, Haiwen Zhou, Qidan Tan, Shiyong Qi   +9 more
wiley   +1 more source

Paradigm shift: PRRSV-mediated active remodeling of the host immune system-From epigenetic domestication to functional hijacking. [PDF]

Front Microbiol
Duan D, Cao C, Qiu L, Li X, Chen H.
europepmc   +1 more source

260. The Unfortunate Consequence of Immunosuppression in a Renal Transplant Patient

, 2021
Franklin Mikell, Rabindra Ghimire
openalex   +1 more source

Immunosuppression-Associated Pathology [PDF]

Pathobiology, 2013
openaire   +2 more sources

Stimuli‐Responsive Supramolecular Biomaterials for Cancer Theranostics

Advanced Science, EarlyView.
The ultimate goal of cancer theranostics is to get imaging agents and therapeutic cargo to tumor sites when and where they are required. “Smart” systems should be developed. This review discusses the characteristics of physiological stimuli, types and action modes of external stimuli, construction approaches and working principles, as well as ...
Wenting Hu, Binglin Ye, Guocan Yu, Feihe Huang, Zhengwei Mao   +4 more
wiley   +1 more source

Care of the immunocompromised cancer patient in the perioperative period: Narrative review. [PDF]

Indian J Anaesth
Dabo-Trubelja A, Gottumukkala V.
europepmc   +1 more source

PD1/PD-L1 dependent immunosuppression by huiPS-derived cell population [PDF]

, 2011
Jonathan Pini, Arieh Moussaieff, Emilie Murris, Reuven Shalom-Feuerstein, Isabelle Petit, Daniel Aberdam, Matthieu Rouleau   +6 more
openalex   +1 more source

Supplementary Figures S1-S5 from CpG Blocks Immunosuppression by Myeloid-Derived Suppressor Cells in Tumor-Bearing Mice

, 2023
Christine Zoglmeier, Helen Bauer, Daniel Nörenberg, Georg Wedekind, Philipp Bittner, Nadja Sandholzer, Moritz Rapp, David Anz, Stefan Endres, Carole Bourquin   +9 more
openalex   +2 more sources

Esketamine/Ketamine: Dual‐Action Mechanisms and Clinical Prospects beyond Anesthesia in Psychiatry, Immunology, and Oncology

Advanced Science, EarlyView.
Esketamine and ketamine are widely used for perioperative analgesia and anesthesia. Despite their established roles in analgesia, sedation, and anesthesia, as well as emerging antidepressant, anti‐tumor, and anti‐inflammatory effects, their clinical use is limited due to side effects and addiction potential.
Yinxin Wang, Jiangang Xu, Xinyu Zhou, Lu Che, Minghan Qiu, Yang Liu, Ming Gao, Zhen Yang   +7 more
wiley   +1 more source

Invasive phaeohyphomycosis due to Parathyridaria percutanea in a liver transplant recipient. [PDF]

BMC Infect Dis
Obana A, Akabane M, Ohashi Y, Bagrodia N, Schenk A, Black S, Washburn K, Wiederhold NP, Cañete-Gibas CF, Meniru J, Nichols C, Sarwar S, Marschalk N.   +12 more
europepmc   +1 more source